You are here: Industry Insights > generics

News List

Teva attracts attention from pharma, private equity for $500M sale of Medis fiercepharma
September 14, 2018
Teva has been working to pay down tens of billions of dollars of debt since it purchased Allergan’s generics suite for more than $40 billion. Now, the company's Medis unit has attracted attention from industry players and private equity firms, according t
Generics could save US Medicare $1 billion per year pharmafile
August 27, 2018
The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according to a study published in the Journal of the American Medical Association.......
FDA approved more generics in July than any previous month pharmafile
August 13, 2018
FDA Commissioner Scott Gottlieb took to Twitter to announce the news that the FDA smashed its previous record for number of generic drug approvals in a single month, authorising a total of 126 such medications throughout July this year.
Mylan says plant remediation dictated in part by which generics to drop fiercepharma
August 10, 2018
Mylan started a comprehensive remediation of its massive Morgantown, West Virginia, plant in June after the FDA criticized management for weak oversight that led to a myriad of problems at the massive facility.
Pfizer's rejig made for growth, but it's also handy for a future split fiercepharma
August 01, 2018
Pfizer’s new three-unit structure may be all about driving growth for now, but don’t count out a long-awaited generics divestment down the line.
South Korea's finished drug market growth driven by generics cphi-online
July 25, 2018
FDF launches at CPhI Korea as country set to become regional hub.
Sanofi to sell generics unit for 1.9 billion Euros pharmatimes
July 17, 2018
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
Sanofi, Advent finally shake hands on $2.2B European generics sale fiercepharma
July 02, 2018
It’s official: Sanofi is finally ready to unload its European generics business.
FDA beefs up generics-use push with radio PSAs fiercepharma
June 13, 2018
The FDA campaign to promote wider use of generics got a bigger media push recently with the addition of radio.
Future growth of Lupin with complex generics, biosimilar and speciality medicines biospectrumasia
June 11, 2018
Lupin is planning to invest heavily in developing high barrier products in complex generics

Previous page 1 2 3 4 5 6 Next page